Updated:
CEN BIOTECH INC
CEN BIOTECH INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001653821, and its reported industry is...
Overview
CEN BIOTECH INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001653821, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-04-14, it reported annual revenue of USD 626,867; net income of USD -18,903,656; total assets of USD 8,440,799 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- CEN BIOTECH INC
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Windsor, Canada
- Incorporated in
- Z4
- Fiscal year end
- December 31
- SEC CIK
- 0001653821
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2021USD | $626,867 | -$18.9M | $8.4M | $193,198 | -$335,504 | |
| FY2020USD | — | $14.2M | $6.3M | $1,908 | -$340,749 | |
| FY2019USD | — | -$5.7M | $7.3M | $3,757 | -$869,350 | |
| FY2018USD | — | -$7.5M | $7.3M | $3,193 | -$1.7M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research CEN BIOTECH INC in Altss
Track this company’s investors, transactions and relationships in Altss.